![Samuel Herschkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Herschkowitz
Directeur/Membre du Conseil chez
ACERUS PHARMACEUTICALS CORPORATION
Profil
Samuel Herschkowitz is the founder.
Dr. Herschkowitz was the founder of Serenity Pharmaceuticals Corp.
(2007), holding the title of Chief Executive Officer & Chairman from 2007 to 2022.
Dr. Herschkowitz is also the founder of Serenity Pharmaceuticals LLC.
Dr. Herschkowitz is currently the Vice Chairman at Acerus Pharmaceuticals Corp.
since 2022 and a Professor at NYU Langone Health.
Former positions include Chief Executive Officer & Director at Prospect Park Capital Corp.
from 2012 to 2020 and Chief Operating & Technical Officer, Director at Delcath Systems, Inc. from 1988 to 2007.
Education includes an undergraduate degree from Syracuse University, conferred in 1971, and a doctorate from State University of New York at Downstate Medical Center, conferred in 1976.
Postes actifs de Samuel Herschkowitz
| Sociétés | Poste | Début |
|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Directeur/Membre du Conseil | 01/02/2022 |
NYU Langone Health
 NYU Langone Health Medical/Nursing ServicesHealth Services Provides medical services | Corporate Officer/Principal | - |
Serenity Pharmaceuticals LLC
 Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs | Directeur Général | - |
Anciens postes connus de Samuel Herschkowitz
| Sociétés | Poste | Fin |
|---|---|---|
Serenity Pharmaceuticals Corp.
 Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in drug development and related technologies | Directeur Général | 01/02/2022 |
| PROSPECT PARK CAPITAL CORP. | Directeur Général | 23/01/2020 |
| DELCATH SYSTEMS, INC. | Directeur Technique/Scientifique/R&D | 17/06/2007 |
Formation de Samuel Herschkowitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Prospect Park Capital Corp.
 Prospect Park Capital Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Serenity Pharmaceuticals Corp.
Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in drug development and related technologies | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
NYU Langone Health
NYU Langone Health Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
Serenity Pharmaceuticals LLC
Serenity Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs | Health Technology |
